Therapeutic strategies against epilepsy in Mediterranean countries: a report from an international collaborative survey (Q38889990)

7 September 2017

title

Therapeutic strategies against epilepsy in Mediterranean countries: a report from an international collaborative survey (English)

1 reference

7 September 2017

1 reference

M Baldy-Moulinier

1

1 reference

7 September 2017

A Covanis

2

1 reference

7 September 2017

S D'urso

3

1 reference

7 September 2017

E Eskazan

4

1 reference

7 September 2017

C Fattore

5

1 reference

7 September 2017

G Gatti

6

1 reference

7 September 2017

J L Herranz

7

1 reference

7 September 2017

S Ibrahim

8

1 reference

7 September 2017

A Khalifa

9

1 reference

7 September 2017

A Mrabet

10

1 reference

7 September 2017

M Y Neufeld

11

1 reference

7 September 2017

E Perucca

12

1 reference

7 September 2017

language of work or name

1 reference

1 December 1998

1 reference

Seizure-European Journal of Epilepsy

7 September 2017

published in

1 reference

7 September 2017

volume

7

1 reference

7 September 2017

issue

6

1 reference

7 September 2017

page(s)

513-520

1 reference

The management of epilepsy in the 1990s. Acquisitions, uncertainties and priorities for future research

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

Standard approach to antiepileptic drug treatment in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

Epilepsy in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

Standard approach to antiepileptic drug treatment in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

Epilepsy in developing countries: a review of epidemiological, sociocultural, and treatment aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

The comparative efficacy of antiepileptic drugs for partial and tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

Antiepileptic drugs as a cause of worsening seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

One drug for epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

Vigabatrin vs. carbamazepine monotherapy in newly diagnosed focal epilepsy: a randomized response conditional cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

The best medicine for febrile seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

Long term outcome of prophylaxis for febrile convulsions

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

Double-blind, randomized trial of diazepam versus placebo for prevention of recurrence of febrile seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

The new generation of antiepileptic drugs: advantages and disadvantages

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2980013-7

7 January 2021

10.1016/S1059-1311(98)80013-7

Identifiers

DOI

1 reference

7 September 2017

1 reference